CN
Home News & Events A breast cancer study on a Chinese brand-name drug has been published on Lancet

A breast cancer study on a Chinese brand-name drug has been published on Lancet

July 27,2020

Back to List

More Press Releases

2018.09.07

Pharma Board Room Interview: Lu Xianping – Chairman and CEO, ChipScreen BioSciences, China
Pharma Board Room Interview: Lu Xianping – Chairman and CEO, ChipScreen BioSciences, China

Full text

2019.08.13

How difficult is drug innovation? This company from the STAR Market claims: We plan to spend 1 billion Yuan over 10 years to select one from 10,000 compounds
How difficult is drug innovation? This company from the STAR Market claims: We plan to spend 1 billion Yuan over 10 years to select one from 10,000 compounds

Full text

2020.06.30

Master Class of SSE about Science & Technology Innovation: Development and Opportunities of Chinese Innovative Drugs
Master Class of SSE about Science & Technology Innovation: Development and Opportunities of Chinese Innovative Drugs

Full text